Aradhana Addepalli
Endocrinology, Diabetes & Metabolism · Detroit, MINPI 1235213315
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,346 of the $2,757 with a category attached, or 85.1%. 23 manufacturers reported payments, led by Medtronic at 25.6% of the total.
Across 126 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$706
- Novo Nordisk$546
- AstraZeneca$225
- Lilly USA, LLC$195
- Amgen$178
- Cardiovascular Systems Inc.$150
- plus $757 from 17 others
What the payments were for
- Travel & lodging$40215%
- Food & beverage$2,34685%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $706 |
| Novo Nordisk | 34 | $546 |
| AstraZeneca(2 entities) | 15 | $225 |
| Lilly USA, LLC | 13 | $195 |
| Amgen(2 entities) | 10 | $178 |
| Cardiovascular Systems Inc. | 1 | $150 |
| Ultragenyx Pharmaceutical Inc. | 5 | $106 |
| Recordati_rare_diseases_inc. | 3 | $85 |
| BD | 5 | $82 |
| Corcept Therapeutics | 4 | $64 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Amarin Pharma, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Dexcom, Inc. | 2 | $41 |
| Neurocrine Biosciences, Inc. | 1 | $38 |
| Pfizer | 2 | $38 |
| Insulet Corporation | 2 | $34 |
| Radius Health, Inc. | 2 | $33 |
| Chiesi USA, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Insmed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,757 in reported general payments places this provider in the 55th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
See all endocrinology, diabetes & metabolism providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $177 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Detroit
- Henry BoneDetroit$120K
- Shobana AthimulamDetroit$14K
- Wael TahaDetroit$12K
- Berhane SeyoumDetroit$11K
- Lowell SchmeltzFarmington Hills$1.3M
- George GrunbergerBloomfield Hills$931K
- Gary EdelsonFarmington Hills$503K
- Michael BrennanSaint Clair Shores$433K
- Jamal HammoudFlint$386K
- Abdulsalam Al KassabRochester Hills$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.